themselves. This process is called MHC restriction and is due to a positive selection process that occurs during T-cell maturation in the thymus. Equally important during T-cell development is a negative selection process that weans out T cells bearing receptors directed against self-peptides in the context of self-MHC molecules. Failure of the negative selection process could lead to leakage of autoreactive T cells from the thymus to the periphery, which would result in autoimmunity.
Activation A large number of autoantigens have been associated with the development of cardiomyositis. They include cardiac a-myosin, adenine nucleotide translocator, p1-adrenergic receptor, calcium channel complex, laminin, heat shock protein, and now cardiac sarcoplasmic reticulum (SR) ATPase.914 Sharaf and colleagues generated a monoclonal IgM antibody (4C11-20.21) against canine SR-ATPase. 4C11-20.21 cross-reacted with cardiac SRATPase from mouse, rat, human, and rabbit. 4C11-20.21 inhibited the enzymatic activity of affinity-purified cardiac SR-ATPase by 75% but had no effect on skeletal muscle SR-ATPase. Eleven CAF1/J mice were immunized with purified canine SR-ATPase, and myocarditis was detected as early as 3 weeks after immunization. Myocarditis can also be induced by growing the hybridoma 4C11-20.21 in the peritoneal space of immunodeficient SCID/CB17 mice. Immunoperoxidase transmission electron microscopy detected localization of 4C11-20.21 Autoantibody directed against intracellular autoantigens is unlikely to be pathogenic unless the cell membrane is already leaky. There is no known mechanism for these antibodies to enter intact cells in sufficient amounts and to escape lysosomal degradation. Obviously, autoantibodies could react against two different proteins, one on the cell surface (for entry) and the other inside the cell (for causing injury). The difficulty in accepting SR-ATPase as an authentic autoantigen is its intracellular location. Although SR-ATPase is adjacent to the T-tubule, it is still topologically segregated from the extracellular milieu.
To identify the cause of autoimmunity is akin to solving a murder mystery. Unless a smoking gun is produced, most of the so-called autoantigens must be presumed innocent. One must carefully assess not only B-cell but also T-cell reactivity against these autoantigens before reaching a guilty verdict. However, with increasing understanding of the mechanism of selftolerance induction, these mysteries will eventually be solved.
